Americans will likely have another COVID-19 vaccine to choose from after the Food and Drug Administration issued an emergency use authorization for Novavax’s COVID-19 vaccine on Wednesday.
It has been cleared for use in persons 18 years of age and older.
Novavax is the fourth COVID-19 vaccine to receive emergency use authorization in the United States from the FDA.
This is a developing story. Check back for updates.